INNT
TOTAL INVALIDATION PROCESSED BY THE IB
04/04/2025
Voltar para busca
Dado oficial do USPTO
PSOREAL
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
46
Atualização mais recente
05/04/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
41, 42
Data de depósito
07/06/2016
Data de registro
17/10/2017
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
03/05/2024
Última transação
05/04/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
84
Localização do titular
DK
Examinador
CALLOWAY,CHRISTINA DENISE
Unidade examinadora
N40
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
LEO Pharma A/S
Representantes
Simor L. Moskowitz Westerman, Hattori, Daniels & Adrian, LLP
Classificação técnica
Classes Nice
Classe 41Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 41
Educational servicesconducting classesseminars and workshops in the field of cancer and dermatologicalhematologicalrenal and endocrine disorders; education servicesproviding on-line classesseminarsworkshops in the field of cancer and dermatologicalhematologicalrenal and endocrine disorders; organizing events for educational purposes in the field of pharmaceutical and medical products; providing on-line non-downloadable electronic publicationsbooksbookletsbrochurespapersperiodical publicationsmagazinesnewspapers and newslettersleafletsinstructional and teaching materials in the field of cancer and dermatologicalhematologicalrenal and endocrine disorders; publication of electronic booksbookletsbrochurespapersperiodical publicationsmagazinesnewspapers and newslettersleafletsinstructional and teaching materials in the field of cancer and dermatologicalhematologicalrenal and endocrine disorders; entertainment servicesproviding online electronic educational and informational games in the field of cancer and dermatologicalhematologicalrenal and endocrine disorders and the treatment thereof
Classe 42
Development of pharmaceutical preparations and medicines; pharmaceutical research services; medical research services in the field of cancer and dermatologicalhematologicalrenal and endocrine disorders; conducting clinical trials for others for pharmaceutical products in the field of cancer and dermatologicalhematologicalrenal and endocrine disorders; providing information in the field of cancer and dermatologicalhematologicalrenal and endocrine disorders about the results of clinical trials for pharmaceutical products; providing temporary use of online software applications containing information on the use of pharmaceutical products and for calculating use of medicine
Publicações
Histórico de despachos e eventos da marca no USPTO.
46 publicações encontradas
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
18/03/2025
INPC
INVALIDATION PROCESSED
18/03/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/03/2025
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
04/01/2025
C71T
CANCELLED SECTION 71
03/05/2024
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
17/10/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
21/05/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
16/03/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
26/01/2018
FIMP
FINAL DISPOSITION PROCESSED
26/01/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
17/01/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
17/10/2017
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/09/2017
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/09/2017
PUBO
PUBLISHED FOR OPPOSITION
01/08/2017
RFNT
REFUSAL PROCESSED BY IB
14/07/2017
NPUB
NOTICE OF PUBLICATION
12/07/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
16/06/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/06/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/06/2017
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
12/06/2017
CNFR
FINAL REFUSAL MAILED
02/06/2017
CNFR
FINAL REFUSAL WRITTEN
01/06/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/05/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/05/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/05/2017
CNRT
NON-FINAL ACTION MAILED
26/04/2017
CNRT
NON-FINAL ACTION WRITTEN
25/04/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
30/03/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
30/03/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
30/03/2017
CNRT
NON-FINAL ACTION MAILED
13/03/2017
CNRT
NON-FINAL ACTION WRITTEN
13/03/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
22/02/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
22/02/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
22/02/2017
RFNP
REFUSAL PROCESSED BY IB
03/02/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
19/01/2017
RFRR
REFUSAL PROCESSED BY MPU
19/01/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
18/01/2017
CNRT
NON-FINAL ACTION WRITTEN
17/01/2017
MAFR
APPLICATION FILING RECEIPT MAILED
31/12/2016
DOCK
ASSIGNED TO EXAMINER
27/12/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
27/12/2016
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
22/12/2016
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace PSOREAL ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.